64
Participants
Start Date
February 28, 2013
Primary Completion Date
August 31, 2015
Study Completion Date
February 16, 2017
SGN-CD19A
SGN-CD19A (IV) once every 21 days (3 weeks) or 42 days (6 weeks)
Memorial Sloan Kettering Cancer Center, New York
H. Lee Moffitt Cancer Center & Research Institute, Tampa
University of Alabama at Birmingham, Birmingham
Stanford Cancer Center, Stanford
City of Hope National Medical Center, Duarte
MD Anderson Cancer Center / University of Texas, Houston
Seagen Inc.
INDUSTRY